Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
The Journal of the American Board of Family Practice
|
April 1, 1990
Movement disorders and new azapirone anxiolytic drugs
M W Jann, J H Froemming, R L Borison
Oral Surgery, Oral Medicine, and Oral Pathology
|
April 1, 1987
Butorphanol as a dental premedication in the mentally retarded
M W Jann, G Fidone, M Gorday, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1992
Interindividual variabilities in haloperidol interconversion and the reduced haloperidol/haloperidol ratio
Y W Lam, W H Chang, M W Jann, et al.
Drug Intelligence & Clinical Pharmacy
|
January 1, 1986
Clinical implications of the neuroleptic-opioid interaction
D R Grothe, L Ereshefsky, M W Jann, et al.
Epilepsia
|
September 1, 1988
Increased valproate serum concentrations upon carbamazepine cessation
M W Jann, G S Fidone, M K Israel, et al.
Psychopharmacology
|
January 1, 1992
Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol
W H Chang, Y W Lam, M W Jann, et al.
Drug Intelligence & Clinical Pharmacy
|
July 1, 1984
Alternative drug therapies for mania: a literature review
M W Jann, J C Garrelts, L Ereshefsky, et al.
The Journal of Clinical Psychiatry
|
September 1, 1986
Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview
L Ereshefsky, M W Jann, S R Saklad, et al.
Drug Intelligence & Clinical Pharmacy
|
July 1, 1984
Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility
S R Saklad, L Ereshefsky, M W Jann, et al.
Journal of Chromatography
|
March 5, 1993
Determination of clozapine and desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection
M C Chung, S K Lin, W H Chang, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
The Journal of the American Board of Family Practice
|
April 1, 1990
Movement disorders and new azapirone anxiolytic drugs
M W Jann, J H Froemming, R L Borison
Oral Surgery, Oral Medicine, and Oral Pathology
|
April 1, 1987
Butorphanol as a dental premedication in the mentally retarded
M W Jann, G Fidone, M Gorday, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1992
Interindividual variabilities in haloperidol interconversion and the reduced haloperidol/haloperidol ratio
Y W Lam, W H Chang, M W Jann, et al.
Drug Intelligence & Clinical Pharmacy
|
January 1, 1986
Clinical implications of the neuroleptic-opioid interaction
D R Grothe, L Ereshefsky, M W Jann, et al.
Epilepsia
|
September 1, 1988
Increased valproate serum concentrations upon carbamazepine cessation
M W Jann, G S Fidone, M K Israel, et al.
Psychopharmacology
|
January 1, 1992
Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol
W H Chang, Y W Lam, M W Jann, et al.
Drug Intelligence & Clinical Pharmacy
|
July 1, 1984
Alternative drug therapies for mania: a literature review
M W Jann, J C Garrelts, L Ereshefsky, et al.
The Journal of Clinical Psychiatry
|
September 1, 1986
Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview
L Ereshefsky, M W Jann, S R Saklad, et al.
Drug Intelligence & Clinical Pharmacy
|
July 1, 1984
Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility
S R Saklad, L Ereshefsky, M W Jann, et al.
Journal of Chromatography
|
March 5, 1993
Determination of clozapine and desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection
M C Chung, S K Lin, W H Chang, et al.
Page
of 10